Evaluating the phenotype of CD163+ M2-like TAMs in 58 acute T-lymphoblastic leukemia (T-ALL) patients revealed that higher numbers of CD163+ cells were correlated with poor prognosis. The gene discussed is CD163; the disease is acute lymphoblastic leukemia.